Experimental Alzheimer’s Drug Slows Cognitive Declines in Large Trial, Drugmaker Eli Lilly Says
An experimental Alzheimer’s medication slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third in a large clinical trial, drugmaker Eli Lilly said Wednesday. From a report: Based on the results, in people with…